Updates from the Field of Cell Therapy in Diabetes

Islet cell transplantation now extends beyond type 1 diabetes, to include patients with chronic pancreatitis via auto-islet transplantation, which does not require immunosuppression. Research has continued to increase the yield and longevity of islet cells. We will review current indications for pancreas versus islet cell transplantation, including examples of cases. We will compare outcomes of transplantation versus conventional therapy, including metabolic effects, glucose counterregulation capabilities, chronic complications of diabetes, and effects of immunosuppression. We will address practical aspects of patient referral and co-management during follow-up for those meeting criteria for transplantation.

Updates from the Field of Cell Therapy for Diabetes

Bernhard Hering, MD

University of Minnesota

Updates from the Field of Cell Therapy in Diabetes

Christine Burt Solorzano, MD

University of Virginia

Updates from the Field of Cell Therapy in Diabetes

Leonor Corsino, MD, MHS

Duke University